Abstract:
Background:
Oral cancer is the second preeminent malignancy in Pakistan after breast cancer, ascribed
to widespread use of numerous perilous chewable tobacco formulations. The Human
Papilloma Virus (HPV) has come forward as a new malefactor of malignant and pre
malignant oral lesions. HPV related oral squamous cell carcinoma (OSCC) constitute an
epidemiological, molecular and clinical distinctive subset of oral cancer. Regardless of
the HPV status being related with molecular and clinical differences, all oral cancers are
managed equally. Proteomic studies may help to understand the differences between
HPV+VE and HPV-VE OSCC and let us to develop biomarkers for early detection,
recurrence and prognosis leading to identification of therapeutic targets which will
further initiate precisional treatment based on the biology of tumors. This study was
designed to determine the association of HPV high-risk genotypes 16/18 in oral mucosa
of chewable tobacco users and OSCC as well as identification of proteins in Oral rinse of
OSCC patients with and without HPV with major focus on search for prospective tumor
biomarker for HPV related OSCC.
Methods:
A case control study was designed with 100 OSCC patients and 200 controls. Persons
addicted to chewable tobacco formulations such as gutka, pan, betel nut and naswar with
or without oral lesions, having no delirious conditions were included. DNA from oral
rinse of 300 subjects was taken. Samples were analysed by both conventional and real
time PCR using “HPV consensus Gp5+/Gp6+ and HPV 16, 18 specific primers”. After
PCR analysis, a random subset of 75 subjects was selected: 25 each of HPV +IVE OSCC,
HPV –IVE OSCC and non- tobacco chewers. The peptides were separated by nanoflow
liquid chromatograph system coupled online to LTQ-Orbitrap Velose mass spectrometer
using a nanoelectrospray ion source (Thermo Scientific, Schwerte, Germany).
Enrichment and protein–protein interaction (PPI) network analysis of the identified
proteins was performed using FunRich: Functional Enrichment analysis tool version
3.1.3. HPV rates and types were compared between controls and OSCC and oral habits
associated and non-associated OSCC samples by Chi-square test. Odds ratios (ORs) and
95% Confidence intervals for HPV and types were obtained by univariate and
multivariate analysis. Posterior error probability (PEP) was calculated using Bayesian
statistics as a probability of false hit using the peptide identification score (s) and length
of peptide. Gene ontology (GO) functional categories, significant interactions and
pathways associated with datasets were identified by using the hypergeometric test and pvalue
correction with the BH and Bonferroni tests. In all statistical analysis, only p-value
<0.05 was considered significant.
Results:
Out of 300 persons, 74/300 (25%) were found to be infected with HPV: “46/100(46%)
from cases and 28/200(14%) from controls”. 26(35%) were infected by “both HPV 16/18
(23(50%) from cases and 3(12%) from controls”. Persons who were infected with HPV
16&18 had higher chances to develop OSCC as compared to those who didn‟t have HPV
16/18 (AOR: 21.4, 95% CI: 5.73 – 80.8). A total of 1995 proteins from HPV +ive OSCC (995), HPV –ive OSCC (816) and control samples (184) respectively were identified.
Pairwise comparison revealed 37% of HPV +ive OSCC proteins were also present in
HPV –ive OSCC samples whereas HPV-ive and HPV +ive OSCC share 18.6% and
17.1% of control proteins respectively. The 7-10 differentially expressed proteins from
74 secretory proteins in HPV +IVE OSCC were observed associated with 10 fold enriched
pathways related to viral mRNA translation. The ribosomal proteins (RPS20, RPLP1,
RLP0, RPS26, RPL12, RPS28 and RPL3) and glycosylated proteins were related to this
pathway.
Conclusion:
The exposure to high risk strains of Human papilloma virus (16/18) in combination (p <
0.001, Adjusted odds ratio; 21.42) can be cause of development of OSCC. Chewing
tobacco may be the cause of HPV transmission in the oral squamous cells through rough
mucosa (p < 0.0001, Adjusted odds ratio; 11.85). To best of our knowledge,
identification and interaction of secretory proteins of HPV +IVE OSCC are reported for the
first time. The extensive ribosomal protein variations and their interaction in viral mRNA
translation pathway may designate them as the potential biomarker for HPV +IVE OSCC.
The protein level expression of RPLP1 and its involvement in OSCC may have been
explored for the first time.